Literature DB >> 8450475

Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility.

G Zhang1, P H Franklin, T F Murray.   

Abstract

A1 adenosine receptors in the rat prepiriform cortex play an important role in the inhibition of bicuculline methiodide-induced convulsions. In the present study we evaluated manipulation of endogenous adenosine in this brain area as a strategy to effect seizure suppression. All compounds evaluated were unilaterally microinjected into the rat prepiriform cortex. Administration of exogenous adenosine afforded a dose-dependent protection (ED50 = 48.1 +/- 8.4 nmol) against bicuculline methiodide-induced seizures, and these anticonvulsant effects were significantly potentiated by treatment with an adenosine kinase inhibitor, 5'-amino-5'-deoxyadenosine; by the adenosine transport blockers, dilazep or nitrobenzylthioinosine 5'-monophosphate; and by an adenosine deaminase inhibitor, 2'-deoxycoformycin. When administered alone, 5'-amino-5'-deoxyadenosine, 5'-iodotubercidin and dilazep were found to be highly efficacious as anticonvulsants with respective ED50 values of 2.6 +/- 0.8, 4.0 +/- 2.7 and 5.6 +/- 1.5 nmol. In contrast, 2'-deoxycoformycin was both less potent and less efficacious. These results suggest that accumulation of endogenous adenosine may contribute to seizure suppression, and that adenosine kinase and adenosine transport may play a pivotal role in the regulation of extracellular levels of adenosine in the central nervous system. The adenosine antagonist, 8-(p-sulfophenyl)theophylline, increased markedly the severity of bicuculline methiodide-induced seizures. Moreover, reduction of extracellular adenosine formation by a focal injection of an ecto-5'-nucleotidase inhibitor, alpha, beta-methyleneadenosine diphosphate, produced generalized seizures (ED50 = 37.3 +/- 22.7 nmol). Together the proconvulsant effect of an adenosine receptor antagonist and the convulsant action of an ecto-5'-nucleotidase inhibitor further support the role of endogenous adenosine as a tonically active antiepileptogenic substance in the rat prepiriform cortex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450475

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

Review 1.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 2.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

Review 3.  The role of adenosine in epilepsy.

Authors:  Landen Weltha; Jesica Reemmer; Detlev Boison
Journal:  Brain Res Bull       Date:  2018-11-20       Impact factor: 4.077

4.  Role of adenosine signaling on pentylenetetrazole-induced seizures in zebrafish.

Authors:  Anna Maria Siebel; Fabiano Peres Menezes; Katiucia Marques Capiotti; Luiza Wilges Kist; Isabel da Costa Schaefer; Juliana Zanetti Frantz; Maurício Reis Bogo; Rosane Souza Da Silva; Carla Denise Bonan
Journal:  Zebrafish       Date:  2015-01-05       Impact factor: 1.985

5.  Increase of adenine nucleotide hydrolysis in rat hippocampal slices after seizures induced by quinolinic acid.

Authors:  Rafael Nicolaidis; Alessandra Nejar Bruno; João José Freitas Sarkis; Diogo Onofre Souza
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

6.  Adenosine: front and center in linking nutrition and metabolism to neuronal activity.

Authors:  Robert W Greene
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

7.  The anticonvulsant BW534U87 depresses epileptiform activity in rat hippocampal slices by an adenosine-dependent mechanism and through inhibition of voltage-gated Na+ channels.

Authors:  J R Dupere; T J Dale; S J Starkey; X Xie
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

8.  Caffeine augmentation of electroconvulsive seizures.

Authors:  A Francis; L Fochtmann
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

Review 9.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

Review 10.  Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

Authors:  K Janes; A M Symons-Liguori; K A Jacobson; D Salvemini
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.